Can chemo stop immunotherapy from backfiring in lung cancer?
Disease control
Not yet recruiting
This study is for people with advanced non-small cell lung cancer that has high PD-L1 levels. Some patients experience rapid tumor growth when treated with immunotherapy alone. The trial will test whether adding chemotherapy to the immunotherapy drug cemiplimab can prevent this d…
Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated May 01, 2026 16:00 UTC